Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.

Date publication

juillet 2016

Journal

Inflammatory bowel diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Fumery M, Pariente B, Sarter H, Charpentier C, Armengol Debeir L, Dupas JL, Coevoet H, Peyrin-Biroulet L, dʼAgay L, Gower-Rousseau C, Savoye G,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27206018

Résumé

Elderly onset (>60 yrs at diagnosis) Crohn's disease (CD) seems to be associated with a better outcome than when diagnosed earlier in life. The aim of this study was to compare the natural history of patients with CD older than 70 years at diagnosis with that of elderly patients diagnosed between 60 and 70 years in the EPIMAD population-based registry.

Mots clés

Adrenal Cortex Hormones, therapeutic use, Age of Onset, Aged, Anti-Inflammatory Agents, Non-Steroidal, therapeutic use, Colectomy, Colon, pathology, Crohn Disease, diagnosis, Disease Progression, Female, Follow-Up Studies, Humans, Ileum, surgery, Immunosuppressive Agents, therapeutic use, Incidence, Male, Mesalamine, therapeutic use, Middle Aged, Phenotype, Sex Distribution, Tumor Necrosis Factor-alpha, antagonists & inhibitors

Référence

Inflamm. Bowel Dis.. 2016 07;22(7):1698-707